Amyloidosis echocardiography

	Amyloidosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification • Primary amyloidosis • Secondary amyloidosis • Familial amyloidosis • Wild-type (senile) amyloidosis • Cardiac amyloidosis • Beta-2 microglobulin related amyloidosis • Gelsolin related amyloidosis • Lysozyme amyloid related amyloidosis • Leucocyte cell-derived chemotaxin 2 related amyloidosis • Fibrinogen A alpha-chain associated amyloidosis
Pathophysiology
Causes
Differentiating Amyloidosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Amyloidosis echocardiography On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Amyloidosis echocardiography All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Amyloidosis echocardiography
CDC on Amyloidosis echocardiography
Amyloidosis echocardiography in the news
Blogs on Amyloidosis echocardiography
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Amyloidosis echocardiography

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]

Overview[edit | edit source]

Echocardiography/Ultrasound[edit | edit source]

Echocardiography may be helpful in the diagnosis of Amyloidosis. Findings on an echocardiography suggestive of Amyloidosis include:^[1]^[2]^[3]
- ‘Sparkling or speckled appearance’ of the LV thickening
- Hypertrophied right ventricle
- Diastolic dysfunction with restrictive filling pattern (in the advanced stages)
- Severe atrial dilatation
- Thickening of the interatrial septum
- Pericardial effusion
- Prominent valves

References[edit | edit source]

↑ Klein AL, Hatle LK, Burstow DJ, Seward JB, Kyle RA, Bailey KR, Luscher TF, Gertz MA, Tajik AJ (April 1989). "Doppler characterization of left ventricular diastolic function in cardiac amyloidosis". J. Am. Coll. Cardiol. 13 (5): 1017–26. PMID 2647814.
↑ Pantazis A, Vischer AS, Perez-Tome MC, Castelletti S (March 2015). "Diagnosis and management of hypertrophic cardiomyopathy". Echo Res Pract. 2 (1): R45–53. doi:10.1530/ERP-15-0007. PMC 4676455. PMID 26693331.
↑ Eshaghian S, Kaul S, Shah PK (2007). "Cardiac amyloidosis: new insights into diagnosis and management". Rev Cardiovasc Med. 8 (4): 189–99. PMID 18192942.

Template:WH Template:WS

[pmid2647814-1] Klein AL, Hatle LK, Burstow DJ, Seward JB, Kyle RA, Bailey KR, Luscher TF, Gertz MA, Tajik AJ (April 1989). "Doppler characterization of left ventricular diastolic function in cardiac amyloidosis". J. Am. Coll. Cardiol. 13 (5): 1017–26. PMID 2647814.

[pmid26693331-2] Pantazis A, Vischer AS, Perez-Tome MC, Castelletti S (March 2015). "Diagnosis and management of hypertrophic cardiomyopathy". Echo Res Pract. 2 (1): R45–53. doi:10.1530/ERP-15-0007. PMC 4676455. PMID 26693331.

[pmid18192942-3] Eshaghian S, Kaul S, Shah PK (2007). "Cardiac amyloidosis: new insights into diagnosis and management". Rev Cardiovasc Med. 8 (4): 189–99. PMID 18192942.

[1]

[2]

[3]